The Amaxa company has over 10 years’ experience in the pharmaceutical market. They work in the fields of oncology, haematology, neurology and neonatology. They specialise in prescription and non-prescription medicines for the treatment of patients suffering from cancer, blood-related diseases, premature birth and other life-threatening or debilitating illnesses. Their core competencies are in the development and promotion of products in the CIS markets. Their team consists of experienced professionals with extensive knowledge of the development of medicine and the pharmaceutical industry. They maintain close ties with key opinion leaders throughout the research and development of their products and services. Their goal is to become a significant player in the Eastern Europe pharmaceutical market, as well as to provide a continuous supply of niche specialty medicines. The Amaxa Pharma management team has many years’ experience in the commercialisation of pharmaceutical products. They provide the necessary expertise in the healthcare industry to establish successful partnerships that offer flexible and reliable services to international markets.
They put people at the centre of everything they do. They care about the interests of their partners, clients and patients. They focus on their customers and react quickly to the needs of patients and healthcare professionals.
Their mission is to provide access to better medicines and services that enable people to live longer and lead a more healthy and active lifestyle.
Their strategy is based on creating a pharmaceutical company always ready for the future. They use all available opportunities for innovation, growth and development. They aim to increase their strength in the market and expand geographically to gain greater access to new projects and products. Partnership plays a major role in their strategy.